( NASDAQ-NMS:SSRX )

News from 3sbio inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 13, 2016, 04:59 ET 3SBio Inc. Selected as a Constituent of the MSCI China Index

3SBio Inc., (HKEX:1530) ("3SBio") today announced that according to an announcement posted on the MSCI Inc. website on May 12, 2016, 3SBio will be...


Mar 07, 2016, 04:07 ET 3SBio's PEG-irinotecan Wins IND Approval From China FDA

SHENYANG, China, March 7, 2016 /PRNewswire/ -- 3SBio Inc., ("3SBio") a leading biotechnology company based in China focusing on researching,...


Mar 04, 2016, 05:23 ET 3SBio Inc. Announces Expansion of its Leadership Team

3SBio Inc. (Hong Kong: 1530)  ("3SBio" and together with its subsidiaries the "3SBio Group") is pleased to announce that Kevin Xiao...


Aug 17, 2015, 10:02 ET 3SBio Inc. Selected as a Constituent of the Hang Seng Composite LargeCap & MidCap Index

3SBio Inc., (HKEX:1530) ("3SBio") today announced that effective September 14, 2015, it will be added as a constituent of the Hang Seng LargeCap...


Jun 22, 2015, 08:55 ET 3SBio Acquires Global Rights to Anti-TNF mAb

3SBio Inc., (HKEX: 1530) ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing...


Aug 07, 2014, 20:00 ET 3SBio Signs Exclusive Patent License Agreement with DiNonA for Leukotuximab

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products,...